Comparison of time to therapy initiation, therapeutic strategies and survival in patients with MDS IB1, IB2 and AML-MR using data of the duesseldorf registries

Felicitas Schulz, Catharina Mundt, Annika Kasprzak, Paul Jaeger, Andrea Kuendgen, Corinna Strupp, Norbert Gattermann, Kathrin Nachtkamp, Sascha Dietrich, Guido Kobbe, Ulrich Germing · 2026

Read Comparison of time to therapy initiation, therapeutic strategies and survival in patients with MDS IB1, IB2 and AML-MR using data of the duesseldorf registries by Felicitas Schulz, Catharina Mundt, Annika Kasprzak, Paul Jaeger, Andrea Kuendgen, Corinna Strupp, Norbert Gattermann, Kathrin Nachtkamp, Sascha Dietrich, Guido Kobbe, Ulrich Germing (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13518492.txt.

Description

Eleven authors use registry data to test a 2022 change in leukemia classification in this 2026 study. The change lowered the blast threshold for acute myeloid leukemia, moving a group once called MDS IB2 into the leukemia class, and the team asked what that means for care.

Their Duesseldorf registries held 928 patients across three groups. Treatment started fastest in the leukemia group, at half a month against two and five months in the MDS groups. Median survival also stepped down across the groups, from twenty-seven to nineteen to twelve months. Under gentler treatments, the MDS groups lived much longer than the leukemia group, which the authors weigh in judging the new boundary.

Catalog record

CREATORFelicitas Schulz, Catharina Mundt, Annika Kasprzak, Paul Jaeger, Andrea Kuendgen, Corinna Strupp, Norbert Gattermann, Kathrin Nachtkamp, Sascha Dietrich, Guido Kobbe, Ulrich Germing
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13518492

Browse the full library · About the Tower of Babel